Breaking News

Chattem Reports Results, Increases Fiscal 2007 Outlook

March 6, 2007

Chattem said sales rose 8% in fiscal 2006 to $300.5 million. Revenue growth for the fiscal year was led by brands such as Gold Bond, Selsun and the launch Icy Hot Pro-Therapy. The increase excludes the divested pHisoderm brand. Fourth quarter sales rose less than 2% to $65.1 million compared to $63.9 million in the prior year fourth quarter.

In early January, Chattem completed the acquisition of five brands from Johnson & Johnson—ACT anti-cavity mouthwash, Cortizone anti-itch product, Unisom OTC sleep-aid, Kaopectate anti-diarrhea product and Balmex diaper-rash product for $410 million.
blog comments powered by Disqus
  • What's Next for the UK?

    Sarah Boumphrey, Euromonitor International||June 24, 2016
    Euromonitor weighs in on the implications for consumer product companies.

  • Henkel Grabs the Sun

    Henkel Grabs the Sun

    Ian Bell, Euromonitor International||June 24, 2016
    Euromonitor's Ian Bell on the impact the purchase will have on the US detergent industry.

  • To The Max

    To The Max

    Melissa Meisel, Associate Editor||June 20, 2016
    Velvet 59 is on the rise at locations like Ricky’s NYC.

  • Take Notice

    Take Notice

    Melissa Meisel , Associate Editor||June 1, 2016
    Packaging trends revolve around trendy artwork, eco-conscious materials—and portability is a plus too!

  • Virtual Reality

    Virtual Reality

    Christine Esposito, Associate Editor||June 1, 2016
    An update on nature-identical ingredients for cosmetics and personal care products.

  • Shiseido Advances in the US

    Shiseido Advances in the US

    Tom Branna, Editorial Director||June 1, 2016
    New facility in Windsor, NJ demonstrates its dedication to the US and other markets outside Japan.